MASTER KEY project: A basket/umbrella trial for rare cancers in Japan.

被引:2
|
作者
Okuma, Hitomi Sumiyoshi
Yonemori, Kan
Shimizu, Toshio
Goto, Yasushi
Honma, Yoshitaka
Morizane, Chigusa
Noguchi, Emi
Sudo, Kazuki
Munakata, Wataru
Sunami, Kuniko
Hiraoka, Nobuyoshi
Kohno, Takashi
Hirakawa, Akihiro
Shibata, Taro
Sukigara, Tamie
Kawai, Akira
Yamamoto, Noboru
Nakamura, Kenichi
Nishida, Toshirou
Fujiwara, Yasuhiro
机构
[1] Natl Canc Ctr, Tokyo, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr, Tokyo, Japan
关键词
D O I
10.1200/JCO.2018.36.15_suppl.TPS2598
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS2598
引用
收藏
页数:1
相关论文
共 26 条
  • [1] MASTER KEY project: A basket/umbrella trial for rare cancers in Japan
    Noda, S.
    Yonemori, K.
    Shirakawa, N.
    Okuma, H. S.
    Shimizu, T.
    Hirakawa, A.
    Shibata, T.
    Sukigara, T.
    Okita, N.
    Kawai, A.
    Yamamoto, N.
    Nakamura, K.
    Mano, H.
    Nishida, T.
    Fujiwara, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 148 - 148
  • [2] MASTER KEY Project Japan and MASTER KEY Asia; an Asian platform for rare cancers
    Okuma, Hitomi
    ANNALS OF ONCOLOGY, 2023, 34 : S1365 - S1365
  • [3] MASTER KEY Project: A platform study for rare cancers in Japan and Asia
    Okuma, Hitomi
    ANNALS OF ONCOLOGY, 2022, 33 : S448 - S448
  • [4] A platform trial with a registry study for rare cancers: MASTER KEY project
    Narita, S. N.
    Okuma, H. S.
    Yonemori, K.
    Sukigara, T.
    Hirakawa, A.
    Munakata, W.
    Okita, N.
    Shimizu, T.
    Shibata, T.
    Kawai, A.
    Yamamoto, N.
    Izutsu, K.
    Muto, M.
    Akita, H.
    Baba, E.
    Nakamura, K.
    Mano, H.
    Nishida, T.
    Fujiwara, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
    Okuma, Hitomi S.
    Yonemori, Kan
    Narita, Shoko N.
    Sukigara, Tamie
    Hirakawa, Akihiro
    Shimizu, Toshio
    Shibata, Taro
    Kawai, Akira
    Yamamoto, Noboru
    Nakamura, Kenichi
    Nishida, Toshiro
    Fujiwara, Yasuhiro
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 596 - 605
  • [6] Clnical development infrastructure for Rare Cancers, MASTER KEY PROJECT
    Yonemori, Kan
    CANCER SCIENCE, 2024, 115 : 1727 - 1727
  • [7] An Asian multi-regional registry study of rare cancers: The MASTER KEY ASIA and MASTER KEY Japan projects.
    Okuma, Hitomi Sumiyoshi
    Yonemori, Kan
    Ishioka, Chikashi
    Baba, Eishi
    Kinoshita, Ichiro
    Muto, Manabu
    Imasa, Marcelo Severino Bulauitan
    Voon, Pei Jye
    de Almeida, Kathleen Yasmin
    Hoo, Hwoei Fen Soo
    Ichimura, Masahiko
    Mizoguchi, Chiharu
    Munakata, Wataru
    Kohsaka, Shinji
    Shibata, Taro
    Yatabe, Yasushi
    Nakamura, Kenichi
    Mano, Hiroyuki
    Yamamoto, Noboru
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project
    Okuma, Hitomi S.
    Fujiwara, Yasuhiro
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 491 - 492
  • [9] Response to "Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project"
    Yamashita, Kenji
    Kaneko, Masayuki
    Narukawa, Mamoru
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 493 - 493
  • [10] CARMA-BROS: CAncers with Rare Molecular Alterations - Basket-umbrella Real-world Observational Study
    Al Agha, F.
    Raptis, S.
    Zhan, L. J.
    Barghout, S. H.
    Patel, D.
    Brown, M. C.
    Xu, W.
    Ho, C.
    Cheung, W.
    Dawe, D.
    Banerji, S.
    Kuruvilla, S.
    Cheema, P.
    Menjak, I.
    Burkes, R.
    Jao, K.
    Fung, A.
    Blais, N.
    Agulnik, J.
    Bouchard, N.
    Galvis, L.
    Juergens, R. A.
    Wheatley-Price, P.
    Moore, S.
    Snow, S.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S134 - S135